| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |